FilingIndex
AGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-KAGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-K
← FDMT · 4D Molecular Therapeutics, Inc.
DEFA14AThe Ballot

4D Molecular Therapeutics, Inc. files DEFA14A

Filed Apr 28, 2026 · 2mo ago · Accession 0001140361-26-017430

Plain English

DEFA14A filed with the SEC.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Company
4D Molecular Therapeutics, Inc.
Ticker
FDMT
CIK
1650648
Form type
DEFA14A
Filing date
Apr 28, 2026
Report date
—
Document
ny20063669x2_defa14a.htm
Size
1024 KB

More from FDMT

8-KMaterial Agreement · New Debt / ObligationJun 29, 20268-KShareholder VoteJun 22, 202610-QThe RecordMay 7, 20268-KResults of OperationsMay 7, 2026DEF 14AThe BallotApr 28, 20268-KExecutive ChangeMar 30, 2026